Ethical Assessments of Emerging Technologies

Ethical Assessments of Emerging Technologies

  • Federica Lucivero
Publisher:SpringerISBN 13: 9783319232829ISBN 10: 3319232827

Paperback & Hardcover deals ―

Amazon IndiaGOFlipkart GOSnapdealGOSapnaOnlineGOJain Book AgencyGOBooks Wagon₹3,503Book ChorGOCrosswordGODC BooksGO

e-book & Audiobook deals ―

Amazon India GOGoogle Play Books ₹43.44Audible GO

* Price may vary from time to time.

* GO = We're not able to fetch the price (please check manually visiting the website).

Know about the book -

Ethical Assessments of Emerging Technologies is written by Federica Lucivero and published by Springer. It's available with International Standard Book Number or ISBN identification 3319232827 (ISBN 10) and 9783319232829 (ISBN 13).

This book systematically addresses the issue of assessing the normative nature of visions of emerging technologies in an epistemologically robust way. In the context of democratic governance of emerging technologies, not only it is important to reflect on technologies’ moral significance, but also to address their emerging and future oriented character. The book proposes an original approach to deal with the issue of “plausible” ethical evaluation of new technologies. Taking its start from current debates about Technology Assessment, the proposed solution emerges as a combination of theoretical and methodological insights from the fields of Philosophy of Technology, Science and Technology Studies and a normative justification based on pragmatist ethics. The book’s main contribution is to engage a diverse and interdisciplinary audience (ethicists, philosophers, social scientists, technology assessment researchers and practitioners) in a reflection concerning the epistemological challenges that are associated to the endeavour of appraising the moral significance of emerging technologies in the attempt of democratically governing them. It brings together concepts and methodologies from different disciplines and shows their synergy in applying them to two specific case studies of emerging biomedical technologies.